Metabolic heterogeneity in TNBCs: A potential determinant of therapeutic efficacy of 2-deoxyglucose and metformin combinatory therapy
<p dir="ltr">Breast cancers (BCs) remain the leading cause of cancer-related deaths among women worldwide. Among the different types of BCs, treating the highly aggressive, invasive, and metastatic triple-negative BCs (TNBCs) that do not respond to hormonal/human epidermal growth fac...
Saved in:
| Main Author: | Samson Mathews Samuel (11008848) (author) |
|---|---|
| Other Authors: | Elizabeth Varghese (11008845) (author), Noothan Jyothi Satheesh (15955284) (author), Chris R. Triggle (15955286) (author), Dietrich Büsselberg (11008857) (author) |
| Published: |
2023
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment with a Combination of Metformin and 2-Deoxyglucose Upregulates Thrombospondin-1 in Microvascular Endothelial Cells: Implications in Anti-Angiogenic Cancer Therapy
by: Samson Mathews Samuel (18808246)
Published: (2019) -
Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells
by: Samson Mathews Samuel (11008848)
Published: (2020) -
Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer
by: Samson Samuel (6828956)
Published: (2019) -
The Obesity Paradox in Cancer, Tumor Immunology, and Immunotherapy: Potential Therapeutic Implications in Triple Negative Breast Cancer
by: Adviti Naik (673163)
Published: (2019) -
Neratinib and metformin: A novel therapeutic approach against HER2-Positive Breast Cancer
by: Kheraldine, Hadeel
Published: (2025)